SU1403991A3 - Способ получени ингибитора фермента превращени ангиотензина и штамм стрептомицета SтRертомYсеS снRомоFUSсUS NRRL 15098,используемый дл его осуществлени - Google Patents

Способ получени ингибитора фермента превращени ангиотензина и штамм стрептомицета SтRертомYсеS снRомоFUSсUS NRRL 15098,используемый дл его осуществлени Download PDF

Info

Publication number
SU1403991A3
SU1403991A3 SU833635270A SU3635270A SU1403991A3 SU 1403991 A3 SU1403991 A3 SU 1403991A3 SU 833635270 A SU833635270 A SU 833635270A SU 3635270 A SU3635270 A SU 3635270A SU 1403991 A3 SU1403991 A3 SU 1403991A3
Authority
SU
USSR - Soviet Union
Prior art keywords
factor
factors
strain
formula
medium
Prior art date
Application number
SU833635270A
Other languages
English (en)
Russian (ru)
Inventor
Стюарт Миндерс Ион
Кристофер Оъконнор Син
Мицуо Накацукаса Вальтер
Original Assignee
Эли Лилли Энд Компани (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/409,764 external-priority patent/US4404282A/en
Priority claimed from US06/409,763 external-priority patent/US4508901A/en
Priority claimed from US06/409,765 external-priority patent/US4404281A/en
Application filed by Эли Лилли Энд Компани (Фирма) filed Critical Эли Лилли Энд Компани (Фирма)
Application granted granted Critical
Publication of SU1403991A3 publication Critical patent/SU1403991A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/04Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SU833635270A 1982-08-19 1983-08-15 Способ получени ингибитора фермента превращени ангиотензина и штамм стрептомицета SтRертомYсеS снRомоFUSсUS NRRL 15098,используемый дл его осуществлени SU1403991A3 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/409,764 US4404282A (en) 1982-08-19 1982-08-19 Process for enzyme inhibitor
US06/409,763 US4508901A (en) 1982-08-19 1982-08-19 Quiuolizine and indolizine enzyme inhibitors
US06/409,765 US4404281A (en) 1982-08-19 1982-08-19 Process for enzyme inhibitors

Publications (1)

Publication Number Publication Date
SU1403991A3 true SU1403991A3 (ru) 1988-06-15

Family

ID=27410818

Family Applications (1)

Application Number Title Priority Date Filing Date
SU833635270A SU1403991A3 (ru) 1982-08-19 1983-08-15 Способ получени ингибитора фермента превращени ангиотензина и штамм стрептомицета SтRертомYсеS снRомоFUSсUS NRRL 15098,используемый дл его осуществлени

Country Status (15)

Country Link
EP (1) EP0103403B1 (enExample)
KR (1) KR860001215B1 (enExample)
AU (1) AU560417B2 (enExample)
DD (1) DD218389A5 (enExample)
DE (1) DE3381244D1 (enExample)
DK (1) DK377883A (enExample)
ES (1) ES8505721A1 (enExample)
FI (1) FI832960A7 (enExample)
GB (1) GB2126217B (enExample)
GR (1) GR78665B (enExample)
IL (1) IL69474A (enExample)
NZ (1) NZ205245A (enExample)
PL (1) PL243461A1 (enExample)
PT (1) PT77190B (enExample)
SU (1) SU1403991A3 (enExample)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316906A (en) * 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines
US4316905A (en) * 1980-07-01 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of various 4-substituted prolines

Also Published As

Publication number Publication date
FI832960L (fi) 1984-02-20
FI832960A0 (fi) 1983-08-18
KR860001215B1 (ko) 1986-08-27
PL243461A1 (en) 1985-01-02
GB2126217A (en) 1984-03-21
DE3381244D1 (de) 1990-04-05
EP0103403B1 (en) 1990-02-28
EP0103403A3 (en) 1986-07-02
ES524874A0 (es) 1985-06-01
EP0103403A2 (en) 1984-03-21
DK377883A (da) 1984-02-20
AU560417B2 (en) 1987-04-09
IL69474A (en) 1986-11-30
AU1790483A (en) 1984-02-23
GR78665B (enExample) 1984-09-27
NZ205245A (en) 1987-01-23
DK377883D0 (da) 1983-08-18
ES8505721A1 (es) 1985-06-01
DD218389A5 (de) 1985-02-06
GB2126217B (en) 1986-04-03
IL69474A0 (en) 1983-11-30
PT77190B (en) 1986-03-20
PT77190A (en) 1983-09-01
KR840005743A (ko) 1984-11-15
GB8321679D0 (en) 1983-09-14
FI832960A7 (fi) 1984-02-20

Similar Documents

Publication Publication Date Title
AU628418B2 (en) Serine analogs of BU-3608 antibodies
FR2555586A1 (fr) Complexe antibiotique bbm-2478
EP0084826B1 (en) Antibiotic compound
US6432978B1 (en) SF2809-I,II,III,IV,V and VI substances exhibiting chymase-inhibiting activities
SU1403991A3 (ru) Способ получени ингибитора фермента превращени ангиотензина и штамм стрептомицета SтRертомYсеS снRомоFUSсUS NRRL 15098,используемый дл его осуществлени
EP0822260B1 (en) Substance fa-70d, process for producing the same, and uses thereof
US4404282A (en) Process for enzyme inhibitor
EP0317292B1 (en) New antibiotics of the mureidomycin group, their preparation, and their therapeutic use
US4404281A (en) Process for enzyme inhibitors
CA1204684A (en) Angiotensin-converting enzyme inhibitors
US4780311A (en) Antihypercholesterolemic tri-yne carbonates
EP0395418B1 (en) A phospholipase A2 inhibitor, method for producing it and pharmaceutical or veterinary formulations comprising said inhibitor
JPH03157372A (ja) Yl―01869p物質及びその製造法
HK1003573B (en) New antibiotics of the mureidomycin group, their preparation, and their therapeutic use
FR2579599A1 (fr) Substance physiologiquement active tpi et procede de preparation
JPH01168700A (ja) 新規な抗生物質
JP2971204B2 (ja) 新規物質wk−2955およびその製造法
CA2020878C (en) Antitumor antibiotic bu-3285t
EP0432697A2 (en) BU-4146T antibiotic
KR20250131699A (ko) 신규한 선형 올리고머 뎁시펩타이드계 화합물 및 이의 용도
JPH08198888A (ja) ジヒドロフェナジン誘導体
NO174432B (no) Fremgangsmaate for fremstilling av antitumor-aktive forbindelser, samt biologisk ren kultur av streptomyces hygroscopicus ATCC 53709
JPH06157520A (ja) 新規物質hq24
JPH0525150A (ja) 新規デカレストリクチン類および関連化合物、それらの製造方法およびそれらの使用
JPH05301857A (ja) Ws63967物質、その製法及び用途